Sun Pharma shares in focus following US launch of LEQSELVITM, settlement with Incyte Corporation
(You can now subscribe to our
(You can now subscribe to our ETMarkets WhatsApp channel
Shares of Sun Pharmaceutical Industries are expected to remain in focus on Tuesday, July 15, after the company announced two significant developments regarding its oral treatment for severe alopecia areata, LEQSELVITM (deuruxolitinib), in the United States.In a regulatory filing on Monday, Sun Pharma informed that it has entered into a settlement and license agreement with Incyte Corporation about the litigation surrounding LEQSELVITM.The litigation had been pending before the United States District Court for the District of New Jersey. Under the terms of the agreement, both Sun Pharma and Incyte will mutually release each other from all claims that were raised or could have been raised in the litigation.As part of the settlement terms, Incyte has granted Sun Pharma a limited, non-exclusive license, along with certain other related patents pertaining to oral deuruxolitinib for specific non-hematology-oncology indications, including alopecia areata, within the United States.In consideration for the settlement and the license granted, Sun Pharma will make an upfront payment to Incyte, along with ongoing royalty payments that will continue until the expiry of the relevant patents. The company clarified that the other specific terms of the agreement remain confidential.In parallel, Sun Pharma also announced the commercial launch of LEQSELVITM (deuruxolitinib) 8 mg tablets in the United States. According to the official announcement, the drug is now available nationwide for prescription to healthcare providers and patients suffering from severe alopecia areata, offering a new treatment option in this space.LEQSELVITM is indicated for the treatment of adult patients diagnosed with severe alopecia areata.Highlighting the importance of this launch, Sun Pharma stated that treatment options for patients living with severe alopecia areata in the U.S. remain limited, underscoring the need for therapies such as LEQSELVITM.The company further disclosed that the drug had demonstrated promising clinical trial results. Specifically, one-third of patients treated with LEQSELVITM regained almost all of their hair by Week 24 of treatment.Moreover, 3% of patients achieved 80% or more scalp coverage in as early as eight weeks.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
9 minutes ago
- Economic Times
Tariff uncertainty to keep markets on edge; healthcare seen as safer bet: Rajesh Palviya
(What's moving Sensex and Nifty Track latest market news, stock tips, Budget 2025, Share Market on Budget 2025 and expert advice, on ETMarkets. Also, is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds .) Subscribe to ET Prime and read the Economic Times ePaper Sensex Today. Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price
Time of India
2 hours ago
- Time of India
Want to invest Rs 1 lakh when you are young? Here is Raamdeo Agrawal's Warren Buffett-style blueprint to compound wealth
At 30, pick a lane: Professional or Passive? Live Events Everybody knows the price, nobody knows the value India and the U.S. (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel If you're 20 years old and sitting on Rs 1 lakh, Motilal Oswal co-founder Raamdeo Agrawal has one piece of advice: don't do anything till you understand it. That, he says, is among the best lessons he's learned from Warren Buffett, and it applies to both investing and a conversation on Groww's investor podcast released on YouTube, the Motilal Oswal Financial Services co-founder urged young investors to resist the pressure to act without clarity. Agrawal said most 20-year-olds underestimate how little they know about the market. 'At the age of 20, what you don't know is a lot of things… So when you see value–price gap, you will have a, what do you call, limited understanding of it.'He recalled his own investing debut, a hostel tip-off that turned into a three-bagger. 'I bought it 15 bucks, and in a year, two years' time, it became 45 bucks,' he said, noting he was around 22 at the time. 'Those kinds of breaks will happen.'Asked where Rs 1 lakh should go at 30, Agrawal said it depends on whether you want to master the game or outsource it.'If I want to make a career in investing… then you should go to the stock market and figure out what is the value, what is the price, what is the earnings growth, what is the RoE, what is the momentum. I mean, it's a full-time job, and it has become very competitive.'Otherwise, 'go and give your money to one of the fund managers and be happy with it.'Agrawal didn't hold back on what he sees as the pitfalls of post-COVID market behaviour. 'Out of 200 million demat accounts, 160 million is less than 5 years… they have no clue what they are buying and selling... (post COVID)… market is very impatient,' he stressed that understanding intrinsic value is the core skill. 'Everybody knows the price. Nobody knows the value. Once you master the formula to discover value, investing becomes simple.'And the real reward, he added, lies in spotting mispriced opportunity. 'Is the return gap between price and value… is it asymmetric? We are looking for asymmetric... Asymmetricity in the return — that's the excitement in the market.'Agrawal dismissed market timing as a flawed strategy. 'Not buying at the bottom is a crime if at all you are trying to time the market,' he said. 'By the time you muster the courage to enter, you've already missed 40% of the upmove.'He advised investors to look beyond narrative and into balance sheets. 'I go straight to 23 financial ratios,' he said. 'If two companies are equally profitable, but one collects its dues in 10 days while the other takes 90 days, the difference is huge.'Despite growing global uncertainty, Agrawal believes India is one of the only two countries in the world, alongside the United States, where macroeconomic growth consistently flows into long-term equity returns. 'There are 170 markets, but only these two allow for extrapolation of economic growth into stock performance,' he said.'India,' he said, 'is more predictable than the U.S.': Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Economic Times
2 hours ago
- Economic Times
Secondary tariffs on Russian oil buyers: A new shockwave for global energy markets
Understanding Secondary Tariffs Global Oil Production and Consumption Landscape Live Events Potential Market Impact Geopolitical Ramifications (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel In a bold geopolitical move, US President Donald Trump has reiterated his intent to impose secondary tariffs on countries that continue purchasing oil from Russia. This move, aimed at pressuring Moscow into a ceasefire in Ukraine, could significantly disrupt global oil markets, intensify geopolitical tensions, and reshape energy tariffs are punitive measures not imposed directly on Russia, but against third-party nations that engage in trade with Russia—particularly in oil, gas, and uranium. The proposed tariffs could be as high as500%, targeting imports from countries that violate US sanctions. This strategy is designed to isolate Russia economically by deterring its trading partners, but it risks collateral damage across global supply of mid-2025, global oil production stands at approximately 101 million barrels per day (bpd), with consumption closely matching at 100.5 million bpd, according to the International Energy Agency (IEA). The top producers include the United States (12.9 million bpd), Saudi Arabia (10.5 million bpd), and Russia (9.8 million bpd). Russia remains a critical supplier, especially to China, India, and parts of Eastern Europe, which have increased imports since the Ukraine war Russian oil flows were completely banned, replacing its supply would be extremely challenging for global markets as it contributes roughly 10% of global supply. Even in an optimistic scenario, the world could replace 5–6 million bpd, leaving a shortfall of 3–5 million secondary tariffs are enacted, they would likely lead to a sharp price increase, global inflation, energy rationing in vulnerable economies and accelerated investment in renewable energy and gas Russian oil indirectly through its buyers could reduce global supply, especially if major importers like India and China face pressure to cut back. This supply shock could push Asian Brent crude prices to exorbitant highs, raising worries over inflation dependent on Russian oil may scramble for alternatives, increasing demand for Middle Eastern and U.S. oil. This could strain existing production capacities and lead to regional energy shortages, particularly in Asia and Eastern the proposed tariffs are not just economic tools—they're geopolitical weapons. If President Trump enforces this tariff on China and India—two of Russia's largest energy customers—could face significant economic and strategic challenges. These tariffs would not only raise the cost of imports but also strain diplomatic ties with the US, forcing both countries to recalibrate their energy and trade in such a high tariff environment, China and India may adopt a multi-pronged strategic approach as a response to the US. Both countries could accelerate deals with Middle Eastern supplies and may find new suppliers from Africa and Latin America. China may boost Yuan based trade to bypass dollar-based sanctions. In addition, diplomatic measures, enhancing renewable investments and boosting domestic production may also expected Trump's proposed secondary tariffs represent a high-stakes gamble. While they aim to pressure Russia into peace talks, the global repercussions could be severe—fuelling inflation, disrupting energy markets, and reshaping geopolitical alliances. As the world watches, the decision could mark a turning point in both the Ukraine conflict and the future of global energy diplomacy.: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)
